{"altmetric_id":4567632,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":2},"twitter":{"unique_users_count":1,"unique_users":["SPDermatology"],"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["277442709108918"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa62b3cf058f610007f3d","doi":"10.1056\/nejm-jw.na39059","first_seen_on":"2015-09-30T00:14:03+00:00","issns":["1533-7820"],"journal":"Journal Watch","last_mentioned_on":1443572026,"links":["http:\/\/www.jwatch.org\/\/na39059\/2015\/09\/29\/tofacitinib-might-be-effective-severe-recalcitrant-atopic"],"pubdate":"2015-09-29T00:00:00+00:00","publisher":"Journal Watch","title":"Tofacitinib Might Be Effective for Severe, Recalcitrant Atopic Dermatitis","type":"article"},"altmetric_score":{"score":0.75,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.75},"context_for_score":{"all":{"total_number_of_other_articles":6417267,"mean":5.8794758110387,"rank":4504587,"this_scored_higher_than_pct":26,"this_scored_higher_than":1675399,"rank_type":"exact","sample_size":6417267,"percentile":26},"similar_age_3m":{"total_number_of_other_articles":201173,"mean":10.011275783906,"rank":128734,"this_scored_higher_than_pct":31,"this_scored_higher_than":63018,"rank_type":"exact","sample_size":201173,"percentile":31},"this_journal":{"total_number_of_other_articles":9047,"mean":3.9654015034269,"rank":6581,"this_scored_higher_than_pct":21,"this_scored_higher_than":1964,"rank_type":"exact","sample_size":9047,"percentile":21},"similar_age_this_journal_3m":{"total_number_of_other_articles":637,"mean":4.6454779874214,"rank":493,"this_scored_higher_than_pct":14,"this_scored_higher_than":90,"rank_type":"exact","sample_size":637,"percentile":14}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}}},"geo":{"twitter":{"US":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/SPDermatology\/statuses\/649014237575184388","license":"gnip","citation_ids":[4567632],"posted_on":"2015-09-30T00:13:46+00:00","author":{"name":"SmartPractice Derm","url":"http:\/\/www.smartpractice.com\/dermatology","image":"https:\/\/pbs.twimg.com\/profile_images\/542737604559376384\/cMtYenjR_normal.jpeg","description":"Focus on providing innovative products and services to help diagnose and treat patients with allergic contact dermatitis. #patchtesting #contactdermatitis","id_on_source":"SPDermatology","tweeter_id":"2777264474","geo":{"lt":33.44838,"ln":-112.07404,"country":"US"},"followers":100},"tweet_id":"649014237575184388"}],"facebook":[{"title":"Tofacitinib Might Be Effective for Severe, Recalcitrant Atopic Dermatitis","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=429286547257866&id=277442709108918","license":"public","citation_ids":[4567632],"posted_on":"2015-09-30T00:13:46+00:00","summary":"Atopic dermatitis (AD) can be severe and require systemic therapy for its management. Systemic corticosteroids are effective but are frequently...","author":{"name":"SmartPractice Dermatology","url":"https:\/\/www.facebook.com\/277442709108918","facebook_wall_name":"SmartPractice Dermatology","image":"https:\/\/graph.facebook.com\/277442709108918\/picture","id_on_source":"277442709108918"}}]}}